BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12371935)

  • 1. Rejection of porcine islet xenografts mediated by CD4+ T cells activated through the indirect antigen recognition pathway.
    Olack BJ; Jaramillo A; Benshoff ND; Kaleem Z; Swanson CJ; Lowell JA; Mohanakumar T
    Xenotransplantation; 2002 Nov; 9(6):393-401. PubMed ID: 12371935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute rejection of orthotopic corneal xenografts in mice depends on CD4(+) T cells and self-antigen-presenting cells.
    Tanaka K; Sonoda K; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2878-84. PubMed ID: 11687532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response.
    Koulmanda M; Laufer TM; Auchincloss H; Smith RN
    Xenotransplantation; 2004 Nov; 11(6):525-30. PubMed ID: 15479462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rat pancreatic islet and skin xenograft survival in CD4 and CD8 knockout mice.
    Krieger NR; Ito H; Fathman CG
    J Autoimmun; 1997 Jun; 10(3):309-15. PubMed ID: 9218759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The degree of phylogenetic disparity of islet grafts dictates the reliance on indirect CD4 T-cell antigen recognition for rejection.
    Rayat GR; Johnson ZA; Beilke JN; Korbutt GS; Rajotte RV; Gill RG
    Diabetes; 2003 Jun; 52(6):1433-40. PubMed ID: 12765954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+ T cell recognition of a single discordant HLA-A2-transgenic molecule through the indirect antigen presentation pathway induces acute rejection of murine cardiac allografts.
    Smith CR; Jaramillo A; Liu W; Tu Y; Kaleem Z; Swanson CJ; Mohanakumar T
    Transplantation; 2001 Jun; 71(11):1640-8. PubMed ID: 11435977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Without CD4 help, CD8 rejection of pig xenografts requires CD28 costimulation but not perforin killing.
    Zhan Y; Brady JL; Sutherland RM; Lew AM
    J Immunol; 2001 Dec; 167(11):6279-85. PubMed ID: 11714791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune mechanisms associated with the rejection of encapsulated neonatal porcine islet xenografts.
    Kobayashi T; Harb G; Rajotte RV; Korbutt GS; Mallett AG; Arefanian H; Mok D; Rayat GR
    Xenotransplantation; 2006 Nov; 13(6):547-59. PubMed ID: 17059582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A critical role for human CD4+ T-cells in rejection of porcine islet cell xenografts.
    Friedman T; Smith RN; Colvin RB; Iacomini J
    Diabetes; 1999 Dec; 48(12):2340-8. PubMed ID: 10580422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of established porcine islet xenografts to humoral rejection by hyperimmune sera.
    Gourlay WA; O'Neil JJ; Hancock WW; Monaco AP; Maki T
    Transplantation; 1999 Sep; 68(6):888-93. PubMed ID: 10515391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CD4+ and CD8+ T cells in the rejection of heart or islet xenografts in recipients with xenotolerance in the innate immune compartment.
    Devos T; Yan Y; Segers C; Rutgeerts O; Laureys J; Gysemans C; Mathieu C; Waer M
    Transplant Proc; 2005; 37(1):516-7. PubMed ID: 15808695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Porcine antigen-specific IFN-γ ELISpot as a potentially valuable tool for monitoring cellular immune responses in pig-to-non-human primate islet xenotransplantation.
    Kim HJ; Yoon IH; Min BH; Kim YH; Shin JS; Kim JM; Kim JS; Nam HY; Lee WW; Park CG
    Xenotransplantation; 2016 Jul; 23(4):310-9. PubMed ID: 27464486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xenoreactive CD4+ T cells and acute rejection of orthotopic guinea pig corneas in mice.
    Tanaka K; Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1827-32. PubMed ID: 10845605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xenograft rejection of porcine islet-like cell clusters in normal and natural killer cell-depleted mice.
    Karlsson-Parra A; Ridderstad A; Wallgren AC; Möller E; Ljunggren HG; Korsgren O
    Transplantation; 1996 May; 61(9):1313-20. PubMed ID: 8629289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
    Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
    Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of costimulatory blockade with anti-inducible costimulator antibody in conjunction with CTLA4Ig on prevention of islet xenograft rejection from rat to mouse.
    Nabeyama K; Yasunami Y; Toyofuku A; Nakano M; Satoh M; Matsuoka N; Ono J; Kamada M; Uede T; Todo S; Ikeda S
    Transplantation; 2004 Dec; 78(11):1590-6. PubMed ID: 15591946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathymic inoculation of donor antigen: an ineffective strategy for prolonging xenograft survival.
    Tran HM; Patel A; Allen RD; O'Connell PJ
    Xenotransplantation; 1999 May; 6(2):147-54. PubMed ID: 10431792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of MyD88 for macrophage-mediated islet xenograft rejection after adoptive transfer.
    Yi S; Wang Y; Chandra AP; O'Hara JM; Wu J; Ouyang L; Burgess JS; Hawthorne W; Wu H; Chadban SJ; O'Connell PJ
    Transplantation; 2007 Mar; 83(5):615-23. PubMed ID: 17353783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peri-graft porcine-specific CD4
    Yoon IH; Chung H; Kim HJ; Nam HY; Shin JS; Kim YH; Park CG
    Xenotransplantation; 2019 Sep; 26(5):e12533. PubMed ID: 31111577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
    Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
    Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.